The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Priti on a news conference at 5. Guaranteed to get the story wrong so hope nobody asks her!
People keep asking the same question as to why Al will not update shareholders when it is blindingly obvious that he would if he was able to which is why he can only give broad hints periodically.
David Wilson mentioned last year the importance of putting a structure together that would apply to diagnostic testing post Covid. At its heart such a structure would prioritise domestic firms and collaboration between them. It was a recognition that we would need to be much better prepared as a country for future outbreaks of a pandemic
What we are now beginning to see is such a structure developing to combat Covid with the likelihood that it would act as a template which could be used for future diagnostic testing. If as seems possible Avct is at the heart of this structure to combat Covid then it could well play a significant part in the future
15 minute Presentation followed by 15 minute questions so likely to start around 8
The downside of Acquis is the wider spread and general lack of liquidity. There is no doubt that Brett intends to move TTAU to ASX or one of the 2 London markets but only after he has put a couple of other pieces in place which would mean joining these markets with a much higher market cap. By this I would imagine he means the publication of the JORC and the involvement of a Major initially developing SH. A strong buy at these prices and an opportunity for us old STGR holders to get our money back!
Further evidence of the potential of affimers on the therapeutic side that more knowledgable posters may wish to further comment on
Confirmation from JVT that the vaccine should prevent serious illness but it may not prevent transmission. Testing will still be needed for many months yet
Great to see AVCT meeting yet another deadline!!
Alastair and his team are dong a fantastic job in trying to get this country out of one of its biggest crises since 2WW. Quite what contribution the people who belittle those efforts are making other than undermine their own investment I will leave it to others to try and explain
Brett has previously stated that the aim is to prove up Specimen Hill, publish the JORC and sell off to a Major to develop and then start again by proving up one of the many other prospects notably Mt Cassidy. The 2 major inflection points are likely to be the publication of the JORC and a movement to a more liquid market in either the UK, Aus or both. Next year should be interesting
And still the same spiteful people post!
Anti Al moaners out in force again without thinking for a moment that the missing deadlines are highly likely to be outside our control and there are clearly limits on how much he can say. COVID going nowhere, excellent progress being made and all to play for early in the New Year
No he would be damaging his reputation if he rushed out a sub standard test like the Chinese one that would undermine the whole affimer diagnostic programme. But then you know that!
The market is beginning to wake up to the fact that not only is testing going to be needed for a very long time but even this incompetent government has finally woken up to the fact that existing LFD’s do not accurately detect infectious people who are likely to spread the virus thus the cancellation of the most recent tender as mentioned by Ophidian. It is a matter of opinion as to whether they are waiting for the test of AVCT but it happens to be mine
Even by his standards a very disappointing response to her question. He could have said the quality of tests were evolving rather than support the inadequate Chinese test
Rolling out millions of newly invented tests !
Guidance updated December 7th. This time it might be us !
Developing the JVT analogy has the shortcomings of other LFD tests and specifically the Innova test over the last few days provided AVCT with an open goal that Al will quite possibly/probably slam into an empty net sometime before the end of this month?
Encouraging report given Al’s recent comment that AVCT were making good progress on a number of other non COVID commercial opportunities regarding diagnostic testing. Plenty of revenue opportunities available if and when there is less need for COVID testing
Good find and maybe an indication that BAMS are selling well